Anna Meyring-Wösten

Anna Meyring-Wösten

Auto-generated profile, based on publicly available information

Anna Meyring-Wösten

Renal Research Institute, New York, USA

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2016 in Clinical Journal of the American Society of Nephrology
Verified
Journal Article
Closed access
PDF file
AMAnna Meyring-Wösten
Anna Meyring-Wösten
HZHanjie Zhang
Hanjie Zhang
XYXiaoling Ye
Xiaoling Ye
DFDoris H. Fuertinger
Doris H. Fuertinger
LCLili Chan
Lili Chan
Peter KotankoPeter Kotanko
Peter Kotanko
Background and objectives Intradialytic hypoxemia has been recognized for decades, but its associations with outcomes have not yet been assessed in a large patient cohort. Design, setting, participants, & measurements Our retrospective cohort study was conducted between January of 2012 and January of 2015. We recorded blood oxygen saturation every minute during hemodialysis in patients with arteriovenous access. A 6-month baseline period with at least 10 treatments with oxygen saturation measurements preceded a 12-month follow-up. Patients were stratified by the presence or absence of prolonged intradialytic hypoxemia defined as oxygen saturation <90% for at least one third of the treatment time. Demographic, laboratory, and treatment data and hospitalization and mortality rates were compared between the groups. Multivariate Cox regression analysis was used to assess baseline predictors of all-cause mortality during follow-up. Results In total, 100 (10%) of 983 patients had prolonged intradialytic hypoxemia. These patients were older (+3.6 years; 95% confidence interval, 0.8 to 6.3), had longer dialysis vintage (+1.2 years; 95% confidence interval, 0.3 to 2.1), and had higher prevalence of congestive heart failure (+10.8%; 95% confidence interval, 1.6 to 20.7) and chronic obstructive pulmonary disease (+13%; 95% confidence interval, 5 to 21.2). They also resembled an inflammatory phenotype, with lower serum albumin levels (−0.1 g/dl; 95% confidence interval, −0.2 to 0) and higher neutrophil-to-lymphocyte ratios (+1; 95% confidence interval, 0.5 to 1.6). They had lower hemoglobin levels (−0.2 g/dl; 95% confidence interval, −0.4 to 0) and required more erythropoietin (+1374 U per hemodialysis treatment; 95% confidence interval, 343 to 2405). During follow-up, all-cause hospitalization (1113 hospitalizations; univariate hazard ratio, 1.46; 95% confidence interval, 1.22 to 1.73) and mortality (89 deaths; adjusted hazard ratio, 1.98; 95% confidence interval, 1.14 to 3.43) were higher in patients with prolonged intradialytic hypoxemia. Conclusions Prolonged intradialytic hypoxemia was associated with laboratory indicators of inflammation, higher erythropoietin requirements, and higher all–cause hospitalization and mortality.

15 January 2016 in Blood Purification
Verified
Journal Article
Open access
PDF file
ICIsrael Campos
Israel Campos
LCLili Chan
Lili Chan
HZHanjie Zhang
Hanjie Zhang
SDSheila Deziel
Sheila Deziel
CVCheryl Vaughn
Cheryl Vaughn
Peter KotankoPeter Kotanko
Peter Kotanko
When kidney failure occurs, patients are at risk for fluid overload states, which can cause pulmonary edema, pleural effusions, and upper airway obstruction. Kidney disease is also associated with impaired respiratory function, as in central sleep apnea or chronic obstructive pulmonary disease. Hence, respiratory and renal diseases are frequently coexisting. Hypoxemia is the terminal pathway of a multitude of respiratory pathologies. The measurement of oxygen saturation (SO2) is a basic and commonly used tool in clinical practice. Both arterial oxygen saturation (SaO2) and central venous oxygen saturation (ScvO2) can be easily obtained in hemodialysis (HD) patients, SaO2 from an arteriovenous access and ScvO2 from a central catheter. Here, we give a brief overview of the anatomy and physiology of the respiratory system, and the different technologies that are currently available to measure oxygen status in dialysis patients. We then focus on literature regarding intradialytic SaO2 and ScvO2. Lastly, we present clinical vignettes of intradialytic drops in SaO2 and ScvO2 in association with different symptoms and clinical scenarios with an emphasis on the pathophysiology of these cases. Given the fact that in the general population hypoxemia is associated with adverse outcomes, including increased mortality, cardiac arrhythmias and cardiovascular events, we posit that intradialytic SO2 may serve as a potential marker to identify HD patients at increased risk for morbidity and mortality.

1 February 2016 in Journal of Theoretical Biology
Verified
Journal Article
Closed access
ARAurelio V de los Reyes
Aurelio V de los Reyes
DFDoris H. Fuertinger
Doris H. Fuertinger
FKFranz Kappel
Franz Kappel
AMAnna Meyring-Wösten
Anna Meyring-Wösten
STStephan Thijssen
Stephan Thijssen
Peter KotankoPeter Kotanko
Peter Kotanko

17 August 2010 in Journal of Cellular Physiology
Verified
Journal Article
Closed access
PDF file
ILIvan Liashkovich
Ivan Liashkovich
AMAnne Meyring
Anne Meyring
AKArmin Kramer
Armin Kramer
VSVictor Shahin
Victor Shahin

15 January 2016 in Blood Purification
Verified
Journal Article
Closed access
PDF file
MHMaggie Han
Maggie Han
SWSchantel Williams
Schantel Williams
MMMelissa Mendoza
Melissa Mendoza
XYXiaoling Ye
Xiaoling Ye
HZHanjie Zhang
Hanjie Zhang
AMAnna Meyring-Wösten
Anna Meyring-Wösten
Background/Aims: Hemodialysis (HD) patients are less active than their healthy counterparts and frequently experience poor sleep. Our aims were to objectively quantify activity and sleep quality in HD patients of an urban population and to determine the effect of providing feedback on activity. Methods: Activity parameters and sleep parameters were collected by a commercially available activity tracker in 29 chronic HD patients. Patients in the feedback group were provided with their activity and sleep data during each HD treatment. Questionnaires were administered at the beginning and at the end of the study. Results: On average, patients walked 8,454 steps/day and slept 349 min/night. Only 28% of the patients were sedentary, defined as walking <5,000 steps/day. Providing feedback did not increase the activity in this urban population. Patients walked significantly less on Sundays compared to other days of the week: 7,024 steps on Sundays vs. 8,633 steps on HD days and 8,732 on non-HD days. It was also found that patients experienced poor sleep quality. HD treatments during shift 1 (6 a.m. to 10 a.m.) interfered with sleep patterns. Most patients reported that physical activity became more important to them after the 5-week period. The tracking device was very well accepted. Conclusion: Interventions to increase physical activity on Sundays could improve physical activity levels overall. Prospective studies are necessary to further explore the use of tracking devices to identify patients at risk and to implement targeted interventions.

1 June 2012 in Journal of Controlled Release
Verified
Journal Article
Closed access
ILIvan Liashkovich
Ivan Liashkovich
AMAnna Meyring
Anna Meyring
HOHans Oberleithner
Hans Oberleithner
VSVictor Shahin
Victor Shahin